These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nitecapone reduces development and symptoms of neuropathic pain after spinal nerve ligation in rats. Kambur O; Männistö PT; Pusa AM; Käenmäki M; Kalso EA; Kontinen VK Eur J Pain; 2011 Aug; 15(7):732-40. PubMed ID: 21216640 [TBL] [Abstract][Full Text] [Related]
3. Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in the rat: modulation by nitecapone, a COMT inhibitor with antioxidant properties. Pertovaara A; Wei H; Kalmari J; Ruotsalainen M Exp Neurol; 2001 Feb; 167(2):425-34. PubMed ID: 11161631 [TBL] [Abstract][Full Text] [Related]
4. Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice. Kambur O; Männistö PT; Viljakka K; Reenilä I; Lemberg K; Kontinen VK; Karayiorgou M; Gogos JA; Kalso E Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):367-73. PubMed ID: 18834357 [TBL] [Abstract][Full Text] [Related]
5. Persistent Catechol-O-methyltransferase-dependent Pain Is Initiated by Peripheral β-Adrenergic Receptors. Ciszek BP; O'Buckley SC; Nackley AG Anesthesiology; 2016 May; 124(5):1122-35. PubMed ID: 26950706 [TBL] [Abstract][Full Text] [Related]
6. Crystal Structure of Catechol O-Methyltransferase Complexed with Nitecapone. Iijima H; Takebe K; Suzuki M; Kobayashi H; Takamiya T; Saito H; Niwa N; Kuwada-Kusunose T Chem Pharm Bull (Tokyo); 2020; 68(5):447-451. PubMed ID: 32378542 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone. Schultz E; Tarpila S; Bäckström AC; Gordin A; Nissinen E; Pohto P Eur J Clin Pharmacol; 1991; 40(6):577-80. PubMed ID: 1884738 [TBL] [Abstract][Full Text] [Related]
8. Catechol-O-methyltransferase inhibition alters pain and anxiety-related volitional behaviors through activation of β-adrenergic receptors in the rat. Kline RH; Exposto FG; O'Buckley SC; Westlund KN; Nackley AG Neuroscience; 2015 Apr; 290():561-9. PubMed ID: 25659347 [TBL] [Abstract][Full Text] [Related]
9. Low catechol-O-methyltransferase and stress potentiate functional pain and depressive behavior, especially in female mice. Zhang X; Kanter K; Chen J; Kim S; Wang Y; Adeyemi C; O'Buckley SC; Nackley AG Pain; 2020 Feb; 161(2):446-458. PubMed ID: 31972854 [TBL] [Abstract][Full Text] [Related]
10. Effect of a novel catechol-O-methyltransferase inhibitor, nitecapone, on the metabolism of L-dopa in healthy volunteers. Kaakkola S; Gordin A; Järvinen M; Wikberg T; Schultz E; Nissinen E; Pentikäinen PJ; Rita H Clin Neuropharmacol; 1990 Oct; 13(5):436-47. PubMed ID: 2272023 [TBL] [Abstract][Full Text] [Related]
11. Central and local administration of Gingko biloba extract EGb 761® inhibits thermal hyperalgesia and inflammation in the rat carrageenan model. Thorpe LB; Goldie M; Dolan S Anesth Analg; 2011 May; 112(5):1226-31. PubMed ID: 21474665 [TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Nackley AG; Tan KS; Fecho K; Flood P; Diatchenko L; Maixner W Pain; 2007 Apr; 128(3):199-208. PubMed ID: 17084978 [TBL] [Abstract][Full Text] [Related]
13. Catechol-O-methyltransferase and pain. Kambur O; Männistö PT Int Rev Neurobiol; 2010; 95():227-79. PubMed ID: 21095465 [TBL] [Abstract][Full Text] [Related]
14. General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase. Kaakkola S; Gordin A; Männistö PT Gen Pharmacol; 1994 Sep; 25(5):813-24. PubMed ID: 7835624 [TBL] [Abstract][Full Text] [Related]
16. Disruption of thermal nociceptive behaviour in mice mutant for the schizophrenia-associated genes NRG1, COMT and DISC1. Walsh J; Tighe O; Lai D; Harvey R; Karayiorgou M; Gogos JA; Waddington JL; O'Tuathaigh CM Brain Res; 2010 Aug; 1348():114-9. PubMed ID: 20561508 [TBL] [Abstract][Full Text] [Related]
17. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols. Ovaska M; Yliniemelä A J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372 [TBL] [Abstract][Full Text] [Related]
18. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice. Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468 [TBL] [Abstract][Full Text] [Related]
19. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism. Brannan T; Prikhojan A; Yahr MD J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195 [TBL] [Abstract][Full Text] [Related]
20. Effect of nitecapone (OR-462) on the pharmacokinetics of levodopa and 3-O-methyldopa formation in cynomolgus monkeys. Cedarbaum JM; Léger G; Reches A; Guttman M Clin Neuropharmacol; 1990 Dec; 13(6):544-52. PubMed ID: 2276119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]